Brazil Chronic Pain Therapeutics Market Report 2022 to 2030

Brazil Chronic Pain Therapeutics Market Analysis

$ 3999

The Brazil Chronic Pain Therapeutics Market is anticipated to experience a growth from $1.858 Bn in 2022 to $3.168 Bn by 2030, with a CAGR of 6.9% during the forecast period of 2022-2030. The drivers of the Brazil Chronic Pain Therapeutics Market include the increasing incidence among the population owing to changing urban lifestyles, continuous advancements in pain management treatments, and crucial regulatory support and healthcare policies implemented by the Brazilian government. The Brazil Chronic Pain Therapeutics Market encompasses various players across different segments, including AbbVie, Pfizer, Novartis, Merck, GSK, Sanofi, Roche, Hypera Pharma, EMS, Biolab Pharma, etc., among various others.

ID: IN10BRPH308 CATEGORY: Pharmaceuticals GEOGRAPHY: Brazil AUTHOR: Dr. Netal Patel

Buy Now

Brazil Chronic Pain Therapeutics Market Analysis Executive Summary

The Brazil Chronic Pain Therapeutics Market is anticipated to experience a growth from $1.858 Bn in 2022 to $3.168 Bn by 2030, with a CAGR of 6.9% during the forecast period of 2022-2030.

Chronic pain refers to persistent discomfort that lasts for long periods, often surpassing the anticipated healing duration of an injury or illness, spanning weeks, months, or even years. It can stem from conditions like arthritis, fibromyalgia, neuropathy, migraines, and back injuries. Pain types include nociceptive (tissue damage), neuropathic (nerve damage), and idiopathic (unknown cause). Addressing chronic pain typically involves a comprehensive approach tailored to the individual's requirements. This may encompass managing medication with analgesics, antidepressants, or anticonvulsants to alleviate pain and enhance mood. Physical therapy and exercise routines play a crucial role in improving mobility and strengthening muscles, thereby reducing strain on affected areas. Psychological interventions, such as cognitive-behavioral therapy (CBT) and mindfulness-based techniques, aim to address the emotional and mental aspects of pain, aiding individuals in better coping. Additionally, interventional procedures like nerve blocks, spinal cord stimulation, or injections may be considered to provide targeted relief for pain.

In Brazil, the general adult population has a significant incidence of chronic pain (35.7%), whereas the senior group has a higher prevalence (47.3%). Also, female sex, aging, low educational attainment, high levels of professional engagement, excessive alcohol use, smoking, central obesity, mood disorders, and sedentarism are all risk factors and are more linked to chronic pain. There was a greater incidence of chronic pain in Brazil's southern and southeast areas.

The drivers of the Brazil Chronic Pain Therapeutics Market include the increasing incidence among the population owing to changing urban lifestyles, continuous advancements in pain management treatments, and crucial regulatory support and healthcare policies implemented by the Brazilian government.

The biggest market shares in Brazil are held by multinational pharma companies like AbbVie, Pfizer, Novartis, and MSD because of their well-established global footprint. Brazilian firms that serve the local population and needs, such as EMS and Hypera Pharma, have a larger market share in particular therapeutic categories.

Market Dynamics

Market Growth Drivers

Changing lifestyles: As urban areas expand and individuals increasingly adopt sedentary behaviors, maintain poor postures, and contend with heightened stress levels, the incidence of chronic pain issues is on the rise. Sedentary lifestyles, often associated with prolonged hours spent sitting or engaging in limited physical activity, contribute to musculoskeletal problems and discomfort. Poor posture, exacerbated by the use of technology and long hours at desks, further compounds these issues. The escalating levels of stress, characteristic of modern urban living, also play a role in the development and exacerbation of chronic pain conditions.

Advancements in treatment: The field of pain management is witnessing continuous advancements due to robust research and development initiatives. Ongoing efforts are dedicated to exploring and introducing novel treatment modalities that offer increased efficacy and improved patient outcomes. These innovations, ranging from pharmaceutical breakthroughs to technological solutions, contribute substantially to the growth and evolution of the chronic pain therapeutics market.

Government support: Regulatory support and healthcare policies implemented by the Brazilian government play a pivotal role in influencing the accessibility and affordability of pain management solutions. Policies geared towards enhancing healthcare access and affordability not only address the immediate needs of individuals suffering from chronic pain but also contribute to the overall growth and sustainability of the chronic pain therapeutics market in Brazil.

Market Constraints

Lack of public awareness: The lack of understanding of chronic pain has become a big problem that leads to societal stigma and ignorance of the treatment options available hence deterring people from seeking prompt help. This unawareness not only delays the diagnosis of chronic pain conditions but also prevents the implementation of appropriate management strategies.

Economic problems: Moreover, limited insurance coverage contributes to high out-of-pocket expenses for chronic pain patients. Many pain medications are neither fully nor partly covered by private or public health insurance companies. As such, this financial pressure acts as a major obstacle in accessing necessary treatments that make it impossible for people with these ailments to manage them effectively.

Inadequate access to healthcare: In rural areas and among low-income groups, disparities in healthcare persist thereby limiting chances of specialized care provision and advanced therapies’ availability. Consequently, numerous individuals do not receive adequate attention or suffer preventable mistreatment leading to continued agony related to acute pain. For example, there is a scarcity of specialist doctors dealing with pain in Brazil with only about 2,000 attending to over 210 Mn Brazilians.

Healthcare Policies and Regulatory Landscape

The National Health Surveillance Agency or ANVISA (Agência Nacional de Vigilância Sanitária) is the Brazilian regulatory agency that is responsible for the approval and supervision of food, cosmetics, tobacco, pharmaceuticals, health services, and medical devices, among others. The agency is connected to the Ministry of Health, which manages ANVISA through a management contract signed periodically. Its primary mandate is to protect and promote public health by ensuring the safety and efficacy of health products, services, and processes. The agency plays a critical role in the registration and evaluation of these products before they enter the Brazilian market, ensuring compliance with national regulations and international standards. Through rigorous inspections and regulatory measures, it aims to guarantee the quality, safety, and effectiveness of healthcare products available to the Brazilian population. In addition to product regulation, it is actively involved in epidemiological surveillance, monitoring health trends, and responding to public health emergencies. The agency collaborates with national and international partners to stay abreast of advancements in healthcare and to contribute to global health initiatives.

Competitive Landscape

Key Players:

AbbVie
Pfizer
Novartis
Merck
GSK
Sanofi
Roche
Hypera Pharma
EMS
Biolab Pharma

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Brazil Chronic Pain Therapeutics Market Segmentation

By Indication

Neuropathic Pain
Back Pain
Headaches
Arthritis Pain
Muscular Pain
Idiopathic Pain
Others

By Drug Class

Analgesics
Opioids
NSAIDs
Anaesthetics
Others

By Route of Administration

Oral
Topical
Parenteral
Others

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By End User

Hospitals
Speciality Clinics
Homecare
Others

Insights10 will provide you with the reports within 10 key parameters which are:

Market Overview
Market Growth Drivers & Restraints
Epidemiology of Disease Type
Market Segmentation
Market Share
Competitive Landscape
Key Company Profiles
Healthcare Policies & Regulatory Framework
Reimbursement Scenario
Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

Establishing market drivers and trends
Analyzing the regulatory landscape to understand future growth
Market Segment based analysis to obtain revenue/volume
Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.